Jagsonpal Pharmaceuticals share news, announcements and annual reports
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹216.09.
2 Nov: open ₹216.80, high ₹219.40, low ₹214.71
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,429 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 5.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.85%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 27,49547.8% delivered
Jagsonpal Pharmaceuticals share news and announcements
550 announcements, routine notices left out, newest first. Page 6 of 11.
May 2022
20 May · Extra Ordinary Meeting
13 May · Board meeting
4 May · Board meeting
Apr 2022
Mar 2022
Feb 2022
28 Feb · Legal
The exchange asked on 25 Feb 2022
22 Feb · Disclosure
22 Feb · Business
22 Feb · Business
18 Feb · Updates
11 Feb · Results
11 Feb · Board meeting
3 Feb · Board meeting
Jan 2022
19 Jan · Board meeting
Not held on this date
Dec 2021
29 Dec · Legal
The exchange asked on 28 Dec 2021
Nov 2021
Oct 2021
20 Oct · Corporate action
19 Oct · Business
19 Oct · Results
Sep 2021
7 Sep · Corporate action
Aug 2021
13 Aug · Results
13 Aug · Results
13 Aug · Board meeting
4 Aug · Board meeting
Jul 2021
12 Jul · Legal
The exchange asked on 9 Jul 2021
Jun 2021
30 Jun · Results
9 Jun · Legal
The exchange asked on 4 Jun 2021
May 2021
25 May · Board meeting
14 May · Board meeting
Apr 2021
29 Apr · Legal
The exchange asked on 23 Apr 2021
Feb 2021
12 Feb · Results
12 Feb · Board meeting
3 Feb · Board meeting
Jan 2021